久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

Hope for HIV patients as drug from GSK goes to human trials

By ANGUS McNEICE in London | China Daily Global | Updated: 2021-12-02 10:39
Share
Share - WeChat
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, on March 21, 2018. [Photo/Agencies]

A human trial into a potential cure for HIV will commence in 2022, United Kingdom pharmaceutical company GSK has announced, after the treatment gained encouraging results from animal testing.

A GSK executive made the announcement in the lead-up to World AIDS Day, which is an international public health campaign established by the World Health Organization and the United Nations that falls on Dec.1 each year.

Kimberly Smith, head of research and development at GSK's HIV arm ViiV Healthcare, said during an investor meeting on Monday that the company plans on testing one of its most promising HIV treatments on humans by summer next year.

Antiviral therapies already exist that can suppress HIV to the point where the virus is undetectable in infected people. But totally eliminating the disease in patients has proved to be a monumental medical challenge, since the virus can lay dormant within cells in the body.

Smith said that the drug from ViiV is capable of "waking up" these dormant viral reservoirs, exposing them to attack from the other therapies and the immune system. Smith said that the drug has been through successful trials in animals including non-human primates.

"The idea is that you have to wake up the latent virus and try to get rid of it," Smith told the Daily Telegraph ahead of the investor meeting. "If it works in humans, then the question will be how do we clear it away once we've induced it."

Smith also said she believes finding a cure for HIV is achievable this decade. Around 38 million people across the world live with the disease, according to the UN.

"Our ultimate goal is always a cure of HIV," Smith told investors. "I hope that we'll contribute to getting there by 2030, if not sooner."

GSK has been at the forefront of HIV drug research since the 1980s, when researchers at company predecessor Burroughs Wellcome first conceived of using the drug azidothymidine, or AZT, as a treatment for the disease.

The company established ViiV to manage its HIV business in 2009, along with two minority shareholders, United States-based Pfizer and Japan-based Shionogi. ViiV has 16 drugs in its HIV portfolio that generated around $6.5 billion in sales last year, according to the company.

But GSK as a whole has struggled in recent years, with an underperforming drug pipeline, investor rumblings over strategy and leadership, and the emergence of a serious rival in AstraZeneca, which has developed one of the most widely-used COVID-19 vaccines.

GSK is also set to lose exclusivity on one of its HIV drug patents in eight years' time, and Smith attempted to quell investor concerns by setting out the company's long-term HIV strategy at the meeting.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 久久久久久久久网站 | 综合刺激网| 免费国产在线观看 | 亚洲成人www| 国产综合久久 | 亚洲欧美国产日韩天堂在线视 | 亚洲成av人影片在线观看 | 午夜免费福利网站 | 黄a视频| 一级一级一片免费高清 | 51国产偷自视频区视频手机播器 | 欧美性猛交xxxxxxxx软件 | 成人爽a毛片在线视频 | 久久亚洲国产 | 国产乱纶| 亚洲精品无码专区在线播放 | 欧美综合视频在线观看 | 国产网站黄色 | 国产露脸3p普通话 | 国产香蕉在线视频一级毛片 | 在线免费观看一区二区三区 | 古代级a毛片可以免费看 | 久久亚洲精品国产精品777777 | 久久精品国产三级不卡 | 欧美日韩黄色 | 欧美一区精品 | 成人自拍视频在线 | 久久久久久亚洲精品不卡 | 欧美日韩中文字幕在线观看 | 日本欧美一区二区三区在线 | 成人黄色一级视频 | 成年人在线免费观看网站 | 亚洲第5页| 国产一二三区在线 | 一级毛片免费完整视频 | 福利视频美女国产精品 | 免费在线一区二区三区 | 九九久久免费视频 | 日韩欧美国产精品 | 久青草免费在线视频 | 精品视频在线播放 |